Cargando…
Characterization of a Bioactive Peptide T14 in the Human and Rodent Substantia Nigra: Implications for Neurodegenerative Disease
The substantia nigra is generally considered to show significant cell loss not only in Parkinson’s but also in Alzheimer’s disease, conditions that share several neuropathological traits. An interesting feature of this nucleus is that the pars compacta dopaminergic neurons contain acetylcholinestera...
Autores principales: | Greenfield, Susan Adele, Ferrati, Giovanni, Coen, Clive W., Vadisiute, Auguste, Molnár, Zoltan, Garcia-Rates, Sara, Frautschy, Sally, Cole, Gregory M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654939/ https://www.ncbi.nlm.nih.gov/pubmed/36361905 http://dx.doi.org/10.3390/ijms232113119 |
Ejemplares similares
-
Soemmerring and the Substantia Nigra
por: Faull, R. L. M, et al.
Publicado: (1968) -
ASL expression in ALDH1A1(+) neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype
por: Lerner, Shaul, et al.
Publicado: (2021) -
The history of the research of iron in parkinsonian substantia nigra
por: Friedman, Andrzej, et al.
Publicado: (2012) -
Isolated substantia nigra involvement in brainstem demyelination
por: Mahale, Rohan R., et al.
Publicado: (2015) -
Nicotine impact on rat substantia nigra compacta
por: Elgayar, Sanaa A M, et al.
Publicado: (2021)